N@N

Market Maker Surveillance Report. WH, JTX, ARNA, PPHM, BASI, ICGN, Winning Stocks With Lowest Price Friction For Monday, Decem

^{Published on 2010-12-20 19:01:03, Last Modified on 2010-12-22 19:51:31 - WOPRAI}
 

December 20, 2010 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 2730 companies with "abnormal" market making, 2556 companies with positive Friction Factors and 2898 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. WSP HOLDINGS LTD-ADR (NYSE:WH), JACKSON HEWITT TAX SERVICE (NYSE:JTX), ARENA PHARMACEUTICALS INC (NASDAQ:ARNA), PEREGRINE PHARMACEUTICALS (NASDAQ:PPHM), BIOANALYTICAL SYSTEMS INC (NASDAQ:BASI), ICAGEN INC (NASDAQ:ICGN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     WH         $0.410       39.42%       1,651,970       52.43%       1,244,968       39.51%       407,002         9,927   
     JTX        $0.360       25.71%       2,759,744       57.97%       2,000,844       42.03%       758,900         21,081  
     ARNA       $0.710       43.03%       17,303,747      54.23%       14,602,041      45.76%       2,701,706       38,052  
     PPHM       $0.540       32.53%       1,978,386       58.10%       1,423,942       41.82%       554,444         10,267  
     BASI       $0.800       29.96%       165,962         53.78%       134,921         43.72%       31,041          388     
     ICGN       $0.670       46.21%       1,411,766       59.32%       961,626         40.41%       450,140         6,719   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ICGN with a dollar gain Monday of $0.67000 and a Friction Factor of 6,719 shares. That means that it only took 6,719 more shares of buying than selling to move ICGN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

WSP HOLDINGS LTD-ADR (NYSE:WH) - WSP Holdings Limited, through its subsidiaries, manufactures oil country tubular goods products. It offers casing, tubing, and drill pipes for oil and natural gas exploration, drilling, and extraction activities, as well as line pipes and green pipes. The company also provides American Petroleum Institute (API) products, which are products manufactured according to the standards formulated by the API; and non-API products, which are products tailor-made to meet customers specifications. It serves oilfields in North America, the Middle East, Asia, Africa, and the Russian Federation through distributors. WSP Holdings Limited was founded in 1999 and is headquartered in Wuxi, the Peoples Republic of China.

JACKSON HEWITT TAX SERVICE (NYSE:JTX) - Jackson Hewitt Tax Service Inc. engages in the computerized preparation of federal, state, and local individual income tax returns in the United States. It also engages in the electronic filing of the customers tax returns. The company offers its services through a network of franchised and company-owned tax offices operating under the Jackson Hewitt Tax Service brand name. In addition, it offers a range of financial products, such as refund anticipation loans, which are made by a third party financial institution to a customer and secured by a customers anticipated federal tax refund; assisted refunds that are provided by third party financial institutions, which offer customers with the ability to have their tax return preparation fees and other charges withheld directly from their tax refund; and gold guarantee, an extended warranty that a customer may purchase whereby the taxpayer may be reimbursed up to a set limit for any additional tax liability owed due to an error in the preparation of the customers tax return. Further, the company provides various disbursement options for financial products, including direct deposit, check, or on the ipower Card, a prepaid Visa card. As of April 30, 2009, its network comprised 5,610 franchised offices and 974 company-owned offices. The company was founded in 1985 and is headquartered in Parsippany, New Jersey.

ARENA PHARMACEUTICALS INC (NASDAQ:ARNA) - Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company also discovers small molecule drug candidates that target G protein-coupled receptors (GPCRs). Its clinical development programs include lorcaserin that has completed Phase III clinical trials for the treatment of weight management; APD791, an anti-thrombotic drug candidate, which completed Phase Ia and Phase Ib clinical trials; APD597 that is in Phase I clinical trials for the treatment of type II diabetes; APD916, which has completed preclinical development for the treatment of narcolepsy and cataplexy; and APD811, a preclinical drug candidate for the treatment of pulmonary arterial hypertension. The companys drug candidates use GPCR-focused drug discovery and development approach, as well as technologies, including Constitutively Activated Receptor Technology and Melanophore Technology. It has collaboration agreements with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop compounds for the potential treatment of type II diabetes and other disorders; and Merck & Co., Inc. to develop therapeutics for atherosclerosis and other disorders. Arena Pharmaceuticals also has a strategic cooperation agreement with Siegfried Ltd to manufacture lorcaserin. The company was founded in 1997 and is based in San Diego, California.

PEREGRINE PHARMACEUTICALS (NASDAQ:PPHM) - PEREGRINE PHARMA

BIOANALYTICAL SYSTEMS INC (NASDAQ:BASI) - Bioanalytical Systems, Inc. provides contract development services and research equipment to pharmaceutical, medical research, and biotechnology companies and institutions worldwide. The company operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment provides various services, including screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; and liquid chromatography and electrochemistry instruments platforms. This segment offers three principal product lines: analytical products, in vivo sampling products, and vetronics products. The analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. The in vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments. These are used by pharmaceutical researchers to dose animals and collect biological samples from the animals. The vetronics products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram) and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

ICAGEN INC (NASDAQ:ICGN) - Icagen, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered small molecule drugs that modulate ion channel targets. Its drug candidates include ICA-105665, which has completed Phase I multiple ascending dose study in healthy volunteers and epilepsy patients for epilepsy and neuropathic pain; and Senicapoc, a small molecule potassium channel inhibitor under the Phase II proof-of-concept clinical trials for the treatment of asthma. The company also engages in conducting research and development activities in various disease areas, including epilepsy, pain, and inflammation. It has a collaborative research and license agreement with Pfizer Inc. for the discovery, development, manufacture, and commercialization of compounds and products that modulate three specific sodium ion channels as new potential treatments for pain and related disorders. The company was founded in 1992 and is based in Durham, North Carolina.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net